"People knew they could come here to get help": An ethnographic study of assisted injection practices at a peer-run 'unsanctioned' supervised drug consumption room in a Canadian setting

AIDS and Behavior

Volumn 18, Issue 3, 2014, Pages 473-485

  McNeil, Ryan ^a   Small, Will ^a,b   Lampkin, Hugh ^c   Shannon, Kate ^a,d   Kerr, Thomas ^a,d  

^a ST PAUL S HOSPITAL   (Canada)

^b SIMON FRASER UNIVERSITY   (Canada)

^c VANCOUVER AREA NETWORK OF DRUG USERS   (Canada)

^d UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Drug users; Ethnography; Harm reduction; HIV risk behaviors; Peer based interventions; Risk environments; Supervised injecting facilities

Indexed keywords

ADULT; ARTICLE; CANADA; CULTURAL ANTHROPOLOGY; DRUG DEPENDENCE TREATMENT; DRUG USE; FEMALE; HARM REDUCTION; HEALTH CARE DELIVERY; HEALTH CENTER; HEALTH SERVICE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTERVENTION STUDY; INTERVIEW; MALE; MIDDLE AGED; PEER GROUP; PSYCHOLOGICAL ASPECT; QUALITATIVE RESEARCH; SUBSTANCE ABUSE; UTILIZATION REVIEW;

ADULT; ANTHROPOLOGY, CULTURAL; CANADA; COMMUNITY HEALTH CENTERS; DRUG USERS; FEMALE; HARM REDUCTION; HEALTH SERVICES ACCESSIBILITY; HEALTH SERVICES NEEDS AND DEMAND; HIV INFECTIONS; HUMANS; INTERVENTION STUDIES; INTERVIEWS AS TOPIC; MALE; MIDDLE AGED; PEER GROUP; QUALITATIVE RESEARCH; SUBSTANCE ABUSE TREATMENT CENTERS; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 84896373623     PISSN: 10907165     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10461-013-0540-y     Document Type: Article

References (86)

1. Degenhardt L, Bucello C, Mathers B, Briegleb C, Ali H, Hickman M, et al. Mortality among regular or dependent users of heroin and other opioids: a systematic review and meta-analysis of cohort studies. Addiction. 2011;106(1):32-51.
2. Degenhardt L, Singleton J, Calabria B, McLaren J, Kerr T, Mehta S, et al. Mortality among cocaine users: a systematic review of cohort studies. Drug Alcohol Depend. 2011;113(2-3):88-95.
3. Wood E, Kerr T, Tyndall MW, Montaner JS. A review of barriers and facilitators of HIV treatment among injection drug users. AIDS. 2008;22(11):1247-56.
4. Aceijas C, Rhodes T. Global estimates of prevalence of HCV infection among injecting drug users. Int J Drug Pol. 2007;18(5):352-8.
5. Mathers BM, Degenhardt L, Phillips B, Wiessing L, Hickman M, Strathdee SA, et al. Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review. Lancet. 2008;372(9651):1733-45.
6. Rhodes T. Risk environments and drug harms: a social science for harm reduction approach. Int J Drug Pol. 2009;20(3):193-201.
7. Rhodes T, Singer M, Bourgois P, Friedman SR, Strathdee SA. The social structural production of HIV risk among injecting drug users. Soc Sci Med. 2005;61(5):1026-44.
8. Rhodes T. The 'risk environment': a framework for understanding and reducing drug-related harm. Int J Drug Pol. 2002;13(2):85-94.
9. Strathdee SA, Hallett TB, Bobrova N, Rhodes T, Booth R, Abdool R, et al. HIV and risk environment for injecting drug users: the past, present, and future. Lancet. 2010;376(9737):268-84.
10. Rhodes T, Wagner K, Strathdee SA, Shannon K, Davidson P, Bourgois P. Structural violence and structural vulnerability within the risk environment: theoretical and methodological perspectives for a social epidemiology of HIV risk among injection drug users and sex workers. In: O'Campo P, Dunn JR, editors. Rethinking social epidemiology: towards a science of change. New York: Springer; 2012. p. 205-30.
11. Quesada J, Hart LK, Bourgois P. Structural vulnerability and health: latino migrant laborers in the United States. Med Anthropol. 2011;30(4):339-62.
12. Richardson L, Wood E, Kerr T. The impact of social, structural and physical environmental factors on transitions into employment among people who inject drugs. Soc Sci Med. 2013;76:126-33.
13. Goldenberg SM, Strathdee SA, Gallardo M, Nguyen L, Lozada R, Semple SJ, et al. How important are venue-based HIV risks among male clients of female sex workers? A mixed methods analysis of the risk environment in nightlife venues in Tijuana, Mexico. Health Place. 2011;17(3):748-56.
14. Rhodes T, Kimber J, Small W, Fitzgerald J, Kerr T, Hickman M, et al. Public injecting and the need for 'safer environment interventions' in the reduction of drug-related harm. Addiction. 2006;101(10):1384-93.
15. Fast D, Small W, Wood E, Kerr T. Coming 'down here': young people's reflections on becoming entrenched in a local drug scene. Soc Sci Med. 2009;69(8):1204-10.
16. Cooper HL, Bossak BH, Tempalski B, Friedman SR, Des Jarlais DC. Temporal trends in spatial access to pharmacies that sell over-the-counter syringes in New York City health districts: relationship to local racial/ethnic composition and need. J Urban Health. 2009;86(6):929-45.
17. Small W, Rhodes T, Wood E, Kerr T. Public injection settings in Vancouver: physical environment, social context and risk. Int J Drug Pol. 2007;18(1):27-36.
18. Parkin S, Coomber R. Public injecting drug use and the social production of harmful practice in high-rise tower blocks (London, UK): a Lefebvrian analysis. Health Place. 2011;17(3):717-26.
19. Rhodes T, Watts L, Davies S, Martin A, Smith J, Clark D, et al. Risk, shame and the public injector: a qualitative study of drug injecting in South Wales. Soc Sci Med. 2007;65(3):572-85.
20. Bourgois P, Schonberg J. Righteous dopefiend. Berkeley: University of California Press; 2009.
21. Bourgois P, Prince B, Moss A. The everyday violence of hepatitis C among young women who inject drugs in San Francisco. Hum Organ. 2004;63(3):253-64.
22. Fairbairn N, Small W, Van Borek N, Wood E, Kerr T. Social structural factors that shape assisted injecting practices among injection drug users in Vancouver, Canada: a qualitative study. Harm Reduct J. 2010;7:20.
23. Epele ME. Gender, violence and HIV: women's survival in the streets. Cult Med Psychiatr. 2002;26(1):33-54.
24. Shannon K, Kerr T, Marshall BDL, Li K, Zhang R, Strathdee SA, et al. Survival sex work involvement as a primary risk factor for hepatitis C virus acquisition in drug-using youths in a Canadian setting. Arch Pediat Adol Med. 2010;164(1):61-5.
25. Shannon K, Rusch M, Shoveller J, Alexson D, Gibson K, Tyndall MW. Mapping violence and policing as an environmental-structural barrier to health service and syringe availability among substance-using women in street-level sex work. Int J Drug Pol. 2008;19(2):140-7.
26. O'Connell JM, Kerr T, Li K, Tyndall MW, Hogg RS, Montaner JS, et al. Requiring help injecting independently predicts incident HIV infection among injection drug users. J Acquir Immune Defic Syndr. 2005;40(1):83-8.
27. Wood E, Spittal PM, Kerr T, Small W, Tyndall MW, O'Shaughnessy MV, et al. Requiring help injecting as a risk factor for HIV infection in the Vancouver epidemic: implications for HIV prevention. Can J Public Health. 2003;94(5):355-9.
28. Kral AH, Bluthenthal RN, Erringer EA, Lorvick J, Edlin BR. Risk factors among IDUs who give injections to or receive injections from other drug users. Addiction. 1999;94(5):675-83.
29. Miller CL, Johnston C, Spittal PM, Li K, Laliberte N, Montaner JS, et al. Opportunities for prevention: hepatitis C prevalence and incidence in a cohort of young injection drug users. Hepatology. 2002;36(3):737-42.
30. Maher L, Jalaludin B, Chant KG, Jayasuriya R, Sladden T, Kaldor JM, et al. Incidence and risk factors for hepatitis C seroconversion in injecting drug users in Australia. Addiction. 2006;101(10):1499-508.
31. Wood E, Tyndall MW, Spittal PM, Li K, Kerr T, Hogg RS, et al. Unsafe injection practices in a cohort of injection drug users in Vancouver: could safer injecting rooms help? CMAJ. 2001;165(4):405-10.
32. Robertson AM, Vera AY, Gallardo M, Pollini RA, Patterson TL, Case P, et al. Correlates of seeking injection assistance among injection drug users in Tijuana, Mexico. Am J Addict. 2010;19(4):357-63.
33. Evans JL, Hahn JA, Page-Shafer K, Lum PJ, Stein ES, Davidson PJ, et al. Gender differences in sexual and injection risk behavior among active young injection drug users in San Francisco (the UFO Study). J Urban Health. 2003;80(1):137-46.
34. Lloyd-Smith E, Rachlis BS, Tobin D, Stone D, Li K, Small W, et al. Assisted injection in outdoor venues: an observational study of risks and implications for service delivery and harm reduction programming. Harm Reduc J. 2010;7:6-10.
35. Lloyd-Smith E, Wood E, Zhang R, Tyndall MW, Montaner JS, Kerr T. Risk factors for developing a cutaneous injection-related infection among injection drug users: a cohort study. BMC Pub Health. 2008;8:405.
36. Kerr T, Fairbairn N, Tyndall M, Marsh D, Li K, Montaner J, et al. Predictors of non-fatal overdose among a cohort of polysubstance-using injection drug users. Drug Alcohol Depend. 2007;87(1):39-45.
37. Milloy MJ, Kerr T, Mathias R, Zhang R, Montaner JS, Tyndall M, et al. Non-fatal overdose among a cohort of active injection drug users recruited from a supervised injection facility. Am J Drug Alcohol Abuse. 2008;34(4):499-509.
38. Marshall BDL, Fairbairn N, Li K, Wood E, Kerr T. Physical violence among a prospective cohort of injection drug users: a gender-focused approach. Drug Alcohol Depend. 2008;97(3):237-46.
39. Scheper-Hughes N. Death without weeping: the violence of everyday life in Brazil. Berkeley: University of California Press; 1992.
40. Wright NM, Tompkins CN, Sheard L. Is peer injecting a form of intimate partner abuse? A qualitative study of the experiences of women drug users. Health Soc Care Community. 2007;15(5):417-25.
41. Tompkins CN, Sheard L, Wright NM, Jones L, Howes N. Exchange, deceit, risk and harm: the consequences for women of receiving injections from other drug users. Drugs Educ Prev Policy. 2006;13(3):281-97.
42. Shannon K, Kerr T, Allinott S, Chettiar J, Shoveller J, Tyndall MW. Social and structural violence and power relations in mitigating HIV risk of drug-using women in survival sex work. Soc Sci Med. 2008;66(4):911-21.
43. Epele ME. Scars, harm and pain: about being injected among drug using Latina women. J Ethn Subst Abuse. 2001;1(1):47-69.
44. Pearshouse R, Elliott R, Canadian HIV/AIDS Legal Network. A helping hand: legal issues related to assisted injection at supervised injection facilities. Toronto: Canadian HIV/AIDS Legal Network; 2007.
45. Wood RA, Wood E, Lai C, Tyndall MW, Montaner JS, Kerr T. Nurse-delivered safer injection education among a cohort of injection drug users: evidence from the evaluation of Vancouver's supervised injection facility. Int J Drug Policy. 2008;19(3):183-8.
46. Fast D, Small W, Wood E, Kerr T. The perspectives of injection drug users regarding safer injecting education delivered through a supervised injecting facility. Harm Reduct J. 2008;5:32.
47. Small W, Wood E, Tobin D, Rikley J, Lapushinsky D, Kerr T. The injection support team: a peer-driven program to address unsafe injecting in a Canadian setting. Subst Use Misuse. 2012;47(5):491-501.
48. Wood E, Tyndall MW, Stoltz J, Small W, Zhang R, O'Connell J, et al. Safer injecting education for HIV prevention within a medically supervised safer injecting facility. Int J Drug Pol. 2005;16(4):281-4.
49. Woolford A. Tainted space: representations of injection drug-users and HIV/AIDS in Vancouver's Downtown Eastside. BC Studies. 2001;129:27-50.
50. Strathdee SA, Patrick DM, Currie SL, Cornelisse PGA, Rekart ML, Montaner JSG, et al. Needle exchange is not enough: lessons from the Vancouver injecting drug use study. AIDS. 1997;11(8):F59-65.
51. Wood E, Kerr T. What do you do when you hit rock bottom? Responding to drugs in the city of Vancouver. Int J Drug Pol. 2006;17(2):55-60.
52. Wood E, Spittal PM, Small W, Kerr T, Li K, Hogg RS, et al. Displacement of Canada's largest public illicit drug market in response to a police crackdown. CMAJ. 2004;170(10):1551-6.
53. Fairbairn N, Wood E, Small W, Stoltz JA, Li K, Kerr T. Risk profile of individuals who provide assistance with illicit drug injections. Drug Alcohol Depend. 2006;82(1):41-6.
54. Wood E, Kerr T, Lloyd-Smith E, Buchner C, Marsh DC, Montaner JS, et al. Methodology for evaluating insite: Canada's first medically supervised safer injection facility for injection drug users. Harm Reduct J. 2004;1:9.
55. Kerr T, Tyndall M, Li K, Montaner J, Wood E. Safer injection facility use and syringe sharing in injection drug users. Lancet. 2005;366(9482):316-8.
56. Wood E, Tyndall MW, Montaner JS, Kerr T. Summary of findings from the evaluation of a pilot medically supervised safer injecting facility. Can Med Assoc J. 2006;175(11):1399-404.
57. Marshall BD, Milloy MJ, Wood E, Montaner JS, Kerr T. Reduction in overdose mortality after the opening of North America's first medically supervised safer injecting facility: a retrospective population-based study. Lancet. 2011;377(9775):1429-37.
58. Milloy MJ, Kerr T, Tyndall M, Montaner J, Wood E. Estimated drug overdose deaths averted by North America's first medically-supervised safer injection facility. PLoS ONE. 2008;3(10):e3351.
59. Small W, Shoveller J, Moore D, Tyndall M, Wood E, Kerr T. Injection drug users' access to a supervised injection facility in Vancouver, Canada: the influence of operating policies and local drug culture. Qual Health Res. 2011;21(6):743-56.
60. Small W, Ainsworth L, Wood E, Kerr T. IDU perspectives on the design and operation of North America's first medically supervised injection facility. Subst Use Misuse. 2011;46(5):561-8.
61. Kerr T, Oleson M, Tyndall MW, Montaner J, Wood E. A description of a peer-run supervised injection site for injection drug users. J Urban Health. 2005;82(2):267-75.
62. Wood E, Kerr T, Spittal PM, Small W, Tyndall MW, O'Shaughnessy MV, et al. An external evaluation of a peer-run "unsanctioned" syringe exchange program. J Urban Health. 2003;80(3):455-64.
63. Solai S, Dubois-Arber F, Benninghoff F, Benaroyo L. Ethical reflections emerging during the activity of a low threshold facility with supervised drug consumption room in Geneva, Switzerland. Int J Drug Policy. 2006;17(1):17-22.
64. Riddell C, Riddell R. Welfare checks, drug consumption, and health. J Hum Resour. 2006;XLI(1):138-61.
65. QSR International. NVivo qualitative data analysis software. 2008.
66. Moore D, Fraser S. Putting at risk what we know: reflecting on the drug-using subject in harm reduction and its political implications. Soc Sci Med. 2006;62(12):3035-47.
67. Ouellet LJ, Jimenez AD, Johnson WA, Wiebel WW. Shooting galleries and HIV disease: variations in places for injecting illicit drugs. Crime Delinquency. 1991;37(1):64-85.
68. Moore D. Governing street-based injecting drug users: a critique of heroin overdose prevention in Australia. Soc Sci Med. 2004;59(7):1547-57.
69. Kerr T, Wood E, Small D, Palepu A, Tyndall MW. Potential use of safer injecting facilities among injection drug users in Vancouver's Downtown Eastside. Can Med Assoc J. 2003;169(8):759-63.
70. Bourgois P. Disciplining addictions: the bio-politics of methadone and heroin in the United States. Cult Med Psychiatr. 2000;24(2):165-95.
71. Fischer B, Turnbull S, Poland B, Haydon E. Drug use, risk and urban order: examining supervised injection sites (SISs) as 'governmentality'. Int J Drug Policy. 2004;15(5-6):357-65.
72. McLean K. The biopolitics of needle exchange in the United States. Crit Public Health. 2011;21(1):71-9.
73. Supreme Court of Canada. Canada (Attorney General) v. PHS Community Services Society. 2011;SCC 44 33556.
74. Boyd SC, Osborn B, MacPherson D. Raise shit! Social action saving lives. Halifax: Fernwood; 2009.
75. Small D, Palepu A, Tyndall MW. The establishment of North America's first state sanctioned supervised injection facility: a case study in culture change. Int J Drug Pol. 2006;17(2):73-82.
76. Kerr T, Small W, Buchner C, Zhang R, Li K, Montaner J, et al. Syringe sharing and HIV incidence among injection drug users and increased access to sterile syringes. Am J Public Health. 2010;100(8):1449-53.
77. Moore D. 'Workers', 'clients' and the struggle over needs: understanding encounters between service providers and injecting drug users in an Australian city. Soc Sci Med. 2009;68(6):1161-8.
78. Sherman SG, Gann DS, Tobin KE, Latkin CA, Welsh C, Bielenson P. "The life they save may be mine": diffusion of overdose prevention information from a city sponsored programme. Int J Drug Policy. 2009;20(2):137-42.
79. Mackenzie S, Pearson C, Frye V, Gómez CA, Latka MH, Purcell DW, et al. Agents of change: peer mentorship as HIV prevention among HIV-positive injection drug users. Subst Use Misuse. 2012;47(5):522-34.
80. Fairbairn N, Small W, Shannon K, Wood E, Kerr T. Seeking refuge from violence in street-based drug scenes: women's experiences in North America's first supervised injection facility. Soc Sci Med. 2008;67(5):817-23.
81. Mitchell D. The right to the city: social justice and the fight for public space. New York: Guilford Press; 2003.
82. Beckett K, Herbert SK. Banished: the new social control in urban American. Oxford: Oxford University Press; 2010.
83. Cooper H, Moore L, Gruskin S, Krieger N. The impact of a police drug crackdown on drug injectors' ability to practice harm reduction: a qualitative study. Soc Sci Med. 2005;61(3):673-84.
84. MacNeil J, Pauly B. Needle exchange as a safe haven in an unsafe world. Drug Alcohol Rev. 2011;30(1):26-32.
85. McLean K. Needle exchange and the geography of survival in the South Bronx. Int J Drug Policy. 2012;23(4):295-302.
86. Parker J, Jackson L, Dykeman M, Gahagan J, Karabanow J. Access to harm reduction services in Atlantic Canada: implications for non-urban residents who inject drugs. Health Place. 2012;18(2):152-62.